More Government Stupidity (what else?) this time credit card abuse

Today the Fed took steps to supposedly crack down on credit card
company practices which are so outrageous that they are virtually
fraudulent (and would actually be illegal for them
[as they still are for you and me]
if certain states and the Congress hadn't passed special exemptions
to usury and other laws).

They have outlawed little tricks such as doubling or tripling your
interest rates on existing balances
EVEN IF YOU NEVER MISS A PAYMENT!
Sounds wonderful but the fine print not mentioned in most news
reports is that these laws won't take effect for years!

Long AFTER the current crisis is probably over.

Also, the fine print permits companies to cancel existing cards
and issue new ones with much higher rates –
guess what they are going to start doing. Come ON, take a WAG.

Anyone with an ounce of common sense would know that these
new regulations need to not only go into effect immediatly,
they should be retroactive if they are to have any real benefit.

But, as we all know, there simply is no one in the current executive branch
of government with the slightest trace of common sense.

john

Comments

Post a Comment

Popular posts from this blog

Climate Change, Too Late To Beg Politicians - Time To Follow The Pentagon And Begin Preparation For The Inevitable.

 As for climate change, I worked on it for decades even in an official capacity as an emergency management coordinator. It is too late to change what will happen by 2050. Politicians simply can't move fast enough, even countries which agreed with the Paris agreement have totally failed to  to meet the goals they agreed to. It is time to stop wasting time, money, and effort on fighting short term climate change and focus our energy on preparing for inevitable financial and social changes we or our descendants will face. Working to make long-term changes would be  useful but that will occur naturally as Red states are washed away (GRIN). I wrote a book about this and am working on the second volume now. "Preparing for Climate Change  Coastal flooding will cost the U.S. billions of dollars within two decades." . second edition ebook  https://www.amazon.com/gp/product/B07TYTG6ZC [ excerpt below ] As far back as 2014 the U.S. military saw climate change as the  biggest strateg
Read more

Does Anyone Still Answer Their Phone?

Today I did my weekly cleanup of phone messages. I change my phone number every two years but the nonsense calls build up to an intolerable level after about 14 months. Today there were 27 saved messages from unanswered calls, some from humans (sort of), a couple from someone speaking Hindustani, and some from computers, all from three companies selling things I would never buy. I live in the country and we know what to do with door-to-door salesmen. Between large hungry dogs and shotguns paired with a backhoe. If I ever answered one of these calls I would still be cursing the caller as my BP went up and up so I never, NEVER answer my phone. There were 7 non sales calls, all from my insurance company, UPMC which is a great insurance plan EXCEPT FOR THE VOLUME OF NONSENSE CALLS they force on me almost daily. No, I do not want to join your conference call about "how to make the most of staying at home" OR the very latest news about COVID or COVID vaccines, only about 4 days beh
Read more

Experimental Anti-Viral MK-4482 To Treat COVID (Rocky Mountain)

 Initial animal tests of a brand new anti-viral medicine has shown what it may treat or even prevent COVID-19. This could be the magic bullet which could defeat the anti-vaXXers and even the mutations. MK-4482 shows potential to prevent and treat SARS-CoV-2 infection. In a press release the NIH just published this information within the hour. " The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists. SARS-CoV-2 is the virus that causes COVID-19. MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already approved by the U.S. Food and Drug Administration for use against COVID-19, must be provided intravenously, making its use primarily limited to clinical settings. In their study, published in the journal  Nature Communications , the scientists found MK-4482 treatment effect
Read more